Elysium Health Aims to Improve People’s Lives through Innovative Science

MIT’s Leonard Guarante co-founded Elysium Health to give agency to consumers regarding their cellular health. Elysium Health is a company that focuses on proactive health. Founded in 2014, Elysium Health is a privately-held biotechnological firm. The organization works directly with the best clinicians, health practitioners, and scientists throughout the world in translating the latest technology and scientific breakthroughs into scientifically potent and effective health products that elicit their actions at the cellular level.

Elysium Health dedicates itself to the identification and development of the most promising and innovative natural ingredients into an effective dietary supplement. Elysium Health envisions longer and healthier lives through the application of extraordinary science. The company’s mission is to provide solutions to the most complex challenges in the health sector through the use of science and technology.

Elysium Health employs a unique approach to achieving their mission. Elysium’s model develops compelling health products from nature to assist their clients in promoting their health in a proactive approach.

Elysium’s supply chain involves multiple quality checks before shipping their products to the consumers. For instance, during the manufacture of Basis, their premier supplement, a total of five purity and quality checks form the foundation of quality control before shipping the product. All of their manufacturing plants are within the United States. The facilities are compliant with the FDA regulations. Therefore, the company releases products of desired purity and quality for human consumption.

Elysium’s scientific advisory group comprises of leaders in technology and science who advocate for better and innovative approaches to health. The highly experienced board members guide the scientific way of the company. The network of scientists and health professionals that are on this board provide practical advice and guidance on the identification and development of products, ongoing studies, and clinical trials. The team uses scientific literature on proactive health to advise on research and clinical trials, as well as maintaining the integrity of the products. The group also actively participates in areas such as aging, biochemistry, and neuroscience to provide Elysium Health with the intellectual resources to build clinically validated products. Furthermore, collaboration with other top-achieving institutions helps them achieve partnerships in clinical studies.

Basis is the first product marketed by Elysium Health. It consists of a clinically-validated combination of two key components that help support cellular well-being. Nicotinamide riboside in the Basis acts as the precursor of NAD+. NAD+ is the coenzyme involved in many metabolic functions within the body.

Comments are closed.